Gene Therapy for Hereditary Deafness
Author Information
Author(s): Liyan Zhang, Fangzhi Tan, Jieyu Qi, Yicheng Lu, Xiaohan Wang, Xuehan Yang, Xiangyan Chen, Xinru Zhang, Jinyi Fan, Yinyi Zhou, Li Peng, Nianci Li, Lei Xu, Shiming Yang, Renjie Chai
Primary Institution: Southeast University
Hypothesis
Can gene therapy effectively treat hereditary deafness caused by genetic mutations?
Conclusion
Gene therapy has shown promising results in restoring hearing function in patients with hereditary deafness caused by specific genetic mutations.
Supporting Evidence
- Gene therapy has restored hearing in over 20 types of genetic deafness model mice.
- Clinical trials have shown significant improvements in auditory function in patients with OTOF mutations.
- AAV vectors are the most commonly used for gene therapy in hereditary deafness.
- Gene therapy has been effective in treating hereditary autosomal recessive deafness 9 (DFNB9).
- Challenges remain due to the complexity of the inner ear and variations in gene mutations.
Takeaway
Scientists are using special medicine to help kids who can't hear because of their genes, and it's working really well!
Methodology
The review summarizes preclinical and clinical research on AAV-mediated gene therapy for hereditary deafness, focusing on advancements and challenges.
Limitations
The complexity of the inner ear structure and variations in gene mutations complicate the effectiveness of gene therapy.
Participant Demographics
The study involved children aged 5 to 8 years with hereditary deafness due to OTOF mutations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website